Buy Full Version
"Global Left Atrial Appendage (LAA) Closure Devices Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Global Left Atrial Appendage (LAA) Closure Devices Market by Product (Epicardial LAA Closure Devices and Endocardial LAA Closure Devices) and by End User (Heart Clinics, Hospitals, and Ambulatory Surgical Clinics) - Opportunity Analysis and Industry Forecast, 2019-2026

Medical Devices & Supplies	LI_184132	Pages: NA	Jan 2020 \| 1258 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

The left atrial appendage (LAA) is a small ear-shaped sac which is present in the wall of the top left chamber of the heart. This sac controls the electrical impulses during atrial fibrillation. The LAA closure devices are the interventional devices that is used to prevent stroke and emboli caused due to atrial fibrillation.

Factors such as increase in number of product approvals of atrial intervention, rise in incidences of atrial fibrillation and heart stroke cases, rise in aging population, disorders due to hypertension, and disturbed lifestyle habits such as smoking drive the market growth. However, stringent regulations by government and high acceptance of alternatives drugs such as warfarin and dabigatran restrain the market growth. Moreover, increase in awareness programs in untapped market provide numerous opportunities for the market growth in the forecast period.

The left atrial appendage closure devices market is segmented on the basis of product, end user, and geography. On the basis of product, it is bifurcated into epicardial LAA closure devices and endocardial LAA closure devices. On the basis of end user, it is divided into heart clinics, hospitals, and ambulatory service centers. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

The key players operating in the market include AtriCure, Inc., Boston Scientific Corporation, Coherex Medical, St. Jude Medical, Occlutech, Lifetech Scientific, SentreHEART, Inc., Avantis Medical Systems, United-Guardian, Inc., and Carestream Health.

Key Benefits

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2016 to 2023 which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis by product helps in understanding the various devices used for LAA closure.
Comprehensive analysis of all geographical regions is provided, which helps in determining the prevailing opportunities.
Key players are profiled and their strategies are analyzed thoroughly, which elucidates the competitive outlook of the global market.

Left Atrial Appendage (LAA) Closure Devices Market Key Segments:

By Product

Epicardial LAA Closure Devices
Endocardial LAA Closure Devices

By End User

Heart Clinics
Hospitals
Ambulatory Service Centers

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

CHAPTER 4 GLOBAL LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICES MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. EPICARDIAL LAA CLOSURE DEVICES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. ENDOCARDIAL LAA CLOSURE DEVICES

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

CHAPTER 5 GLOBAL LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICES MARKET, BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HERAT CLINICS

5.2.1. Market size and forecast

5.3. HOSPITALS

5.3.1. Market size and forecast

5.4. AMBULATORY SERVICE CENTERS

5.4.1. Market size and forecast

CHAPTER 6 GLOBAL LEFT ATRIAL APPENDAGE (LAA) CLOSURE DEVICES MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Left Atrial Appendage (LAA) Closure Devices Market, by Product
6.2.5. North America Left Atrial Appendage (LAA) Closure Devices Market, by End User

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe Left Atrial Appendage (LAA) Closure Devices Market, by Product
6.3.5. Europe Left Atrial Appendage (LAA) Closure Devices Market, by End User

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Left Atrial Appendage (LAA) Closure Devices Market, by Product
6.4.5. Asia-Pacific Left Atrial Appendage (LAA) Closure Devices Market, by End User

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Saudi Arabia market size and forecast
6.5.3.3. South Africa market size and forecast
6.5.3.4. Rest of LAMEA market size and forecast

6.5.4. LAMEA Left Atrial Appendage (LAA) Closure Devices Market, by Product
6.5.5. LAMEA Left Atrial Appendage (LAA) Closure Devices Market, by End User

CHAPTER 7 COMPANY PROFILES

7.1. ATRICURE, INC.

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. BOSTON SCIENTIFIC CORPORATION

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. COHEREX MEDICAL

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. ST. JUDE MEDICAL

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. OCCLUTECH

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. LIFETECH SCIENTIFIC

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. SENTREHEART, INC.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. AVANTIS MEDICAL SYSTEMS

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. UNITED-GUARDIAN, INC.

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. CARESTREAM HEALTH

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,041 Data Pack/Excel ~~$3,840~~ $3,379 Single User License ~~$5,370~~ $4,726 Five User License ~~$6,450~~ $5,676 Enterprise User License ~~$8,995~~ $7,916

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com